Reviva Pharmaceuticals Holdings (RVPH) Shares Issued (2021 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Shares Issued of $569098.0 for Q1 2026, up 259.97% sequentially from $158098.0 in Q4 2025, and down 83.52% YoY from $3.5 million in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Shares Issued (2021 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Shares Issued for 6 years, with the latest figure at $569098.0 in Q1 2026.
- Quarterly Shares Issued fell 83.52% year-over-year to $569098.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $569098.0 (down 83.52% YoY) and the FY2025 annual result came in at $158098.0, down 72.22% from the prior year.
- Shares Issued grew to $569098.0 in Q1 2026 per RVPH's latest filing, from $158098.0 in the prior quarter.
- Over five years, Shares Issued peaked at $3.5 million in Q1 2025 and troughed at $158098.0 in Q4 2023.
- A 5-year average of $1.3 million and a median of $844016.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2023: Shares Issued plunged 85.2% in 2022, then jumped 1247.9% in 2023.
- Over 5 years, Shares Issued stood at $1.0 million in 2022, then plunged by 84.26% to $158098.0 in 2023, then soared by 259.97% to $569098.0 in 2024, then plunged by 72.22% to $158098.0 in 2025, then soared by 259.97% to $569098.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $569098.0, $158098.0, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Reviva Pharmaceuticals Holdings | 6.74 Mn | 6.74 Mn | - | 569,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 569,098.00 |
| Jun 30, 2026 | 569,098.00 |
| Mar 31, 2026 | 569,098.00 |
| Mar 31, 2026 | 569,098.00 |
| Dec 31, 2025 | 158,098.00 |
| Dec 31, 2025 | 158,098.00 |
| Sep 30, 2025 | 3.13 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 569,098.00 |
| Dec 31, 2024 | 569,098.00 |
| Sep 30, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 844,016.00 |
| Mar 31, 2024 | 844,016.00 |